Trial intelligence / Profile preview

Betamethasone shampoo vs ketoconazole gel in inflammatory seborrheic dermatitis of the scalp

2007-007088-25Phase 2Completed

Sponsor
Pierre Fabre Laboratories
Start
Jan 2008
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of betamethasone dipropionate in seborrheic dermatitis (SD) (2 arms), sponsored by Pierre Fabre Laboratories. Primary endpoint: Change in clinical global sum score (erythema + scaling) at Day 14 on each half head. Started Jan 2008; status: completed.

02

Drugs

betamethasone dipropionate
03

Conditions

seborrheic dermatitis (SD)

Beyond the preview

Go deeper on 2007-007088-25.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-007088-25.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call